ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Molecular Diagnostics Infectious Disease Testing Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-33P10213
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Molecular Diagnostics Infectious Disease Testing Market Research Report 2022
BUY CHAPTERS

Global Molecular Diagnostics Infectious Disease Testing Market Research Report 2025

Code: QYRE-Auto-33P10213
Report
March 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott Laboratories
BD
bioMérieux
Thermo Fisher Scientific
F.Hoffmann-La Roche
Siemens AG
Veridex
Luminex
Qiagen NV
Genomix Biotech
Biotheranostics
GenMark Diagnostics

Molecular Diagnostics Infectious Disease Testing Market Size

The global market for Molecular Diagnostics Infectious Disease Testing was valued at US$ 5855 million in the year 2024 and is projected to reach a revised size of US$ 9400 million by 2031, growing at a CAGR of 7.1% during the forecast period.

Molecular Diagnostics Infectious Disease Testing Market

Molecular Diagnostics Infectious Disease Testing Market

Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others.
Molecular diagnostics is a technology that diagnoses diseases by detecting and analyzing biomarkers (such as DNA, RNA, proteins, etc.). In infectious disease testing, molecular diagnostics can be used to detect the nucleic acid sequences of pathogens to determine whether infection is viral or bacterial. Traditional infectious disease detection methods usually require tedious culture and detection steps, while molecular diagnostics can extract nucleic acids directly from samples and perform rapid and accurate detection. This method has the advantages of high sensitivity, high specificity and rapid response, which can detect the disease at an early stage, avoid the spread of the disease, and better control the outbreak of infectious diseases. At present, molecular diagnosis has been widely used in the detection of various infectious diseases, such as AIDS, hepatitis, tuberculosis, influenza, new coronavirus, etc., providing important support and help for the prevention and control of infectious diseases.
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostics Infectious Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostics Infectious Disease Testing.
The Molecular Diagnostics Infectious Disease Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Molecular Diagnostics Infectious Disease Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Diagnostics Infectious Disease Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Molecular Diagnostics Infectious Disease Testing Market Report

Report Metric Details
Report Name Molecular Diagnostics Infectious Disease Testing Market
Accounted market size in year US$ 5855 million
Forecasted market size in 2031 US$ 9400 million
CAGR 7.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Laboratory Research
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, BD, bioMérieux, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens AG, Veridex, Luminex, GenMark Diagnostics, Qiagen NV, Genomix Biotech, BioTheranostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Molecular Diagnostics Infectious Disease Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Molecular Diagnostics Infectious Disease Testing Market growing?

Ans: The Molecular Diagnostics Infectious Disease Testing Market witnessing a CAGR of 7.1% during the forecast period 2025-2031.

What is the Molecular Diagnostics Infectious Disease Testing Market size in 2031?

Ans: The Molecular Diagnostics Infectious Disease Testing Market size in 2031 will be US$ 9400 million.

Who are the main players in the Molecular Diagnostics Infectious Disease Testing Market report?

Ans: The main players in the Molecular Diagnostics Infectious Disease Testing Market are Abbott Laboratories, BD, bioMérieux, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens AG, Veridex, Luminex, GenMark Diagnostics, Qiagen NV, Genomix Biotech, BioTheranostics

What are the Application segmentation covered in the Molecular Diagnostics Infectious Disease Testing Market report?

Ans: The Applications covered in the Molecular Diagnostics Infectious Disease Testing Market report are Hospital, Laboratory Research

What are the Type segmentation covered in the Molecular Diagnostics Infectious Disease Testing Market report?

Ans: The Types covered in the Molecular Diagnostics Infectious Disease Testing Market report are Bacterial Infectious Disease Testing, Viral Infectious Disease Testing, Parasitic Infectious Disease Testing

Recommended Reports

Molecular Diagnostics

Infectious Disease Diagnostics

Nucleic Acid & PCR

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Bacterial Infectious Disease Testing
1.2.3 Viral Infectious Disease Testing
1.2.4 Parasitic Infectious Disease Testing
1.3 Market by Application
1.3.1 Global Molecular Diagnostics Infectious Disease Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Laboratory Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics Infectious Disease Testing Market Perspective (2020-2031)
2.2 Global Molecular Diagnostics Infectious Disease Testing Growth Trends by Region
2.2.1 Global Molecular Diagnostics Infectious Disease Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Molecular Diagnostics Infectious Disease Testing Historic Market Size by Region (2020-2025)
2.2.3 Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Region (2026-2031)
2.3 Molecular Diagnostics Infectious Disease Testing Market Dynamics
2.3.1 Molecular Diagnostics Infectious Disease Testing Industry Trends
2.3.2 Molecular Diagnostics Infectious Disease Testing Market Drivers
2.3.3 Molecular Diagnostics Infectious Disease Testing Market Challenges
2.3.4 Molecular Diagnostics Infectious Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics Infectious Disease Testing Players by Revenue
3.1.1 Global Top Molecular Diagnostics Infectious Disease Testing Players by Revenue (2020-2025)
3.1.2 Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Players (2020-2025)
3.2 Global Molecular Diagnostics Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Molecular Diagnostics Infectious Disease Testing Revenue
3.4 Global Molecular Diagnostics Infectious Disease Testing Market Concentration Ratio
3.4.1 Global Molecular Diagnostics Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Infectious Disease Testing Revenue in 2024
3.5 Global Key Players of Molecular Diagnostics Infectious Disease Testing Head office and Area Served
3.6 Global Key Players of Molecular Diagnostics Infectious Disease Testing, Product and Application
3.7 Global Key Players of Molecular Diagnostics Infectious Disease Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics Infectious Disease Testing Breakdown Data by Type
4.1 Global Molecular Diagnostics Infectious Disease Testing Historic Market Size by Type (2020-2025)
4.2 Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Type (2026-2031)
5 Molecular Diagnostics Infectious Disease Testing Breakdown Data by Application
5.1 Global Molecular Diagnostics Infectious Disease Testing Historic Market Size by Application (2020-2025)
5.2 Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Molecular Diagnostics Infectious Disease Testing Market Size (2020-2031)
6.2 North America Molecular Diagnostics Infectious Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2020-2025)
6.4 North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Diagnostics Infectious Disease Testing Market Size (2020-2031)
7.2 Europe Molecular Diagnostics Infectious Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2020-2025)
7.4 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size (2020-2031)
8.2 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics Infectious Disease Testing Market Size (2020-2031)
9.2 Latin America Molecular Diagnostics Infectious Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2020-2025)
9.4 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size (2020-2031)
10.2 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Introduction
11.1.4 Abbott Laboratories Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Molecular Diagnostics Infectious Disease Testing Introduction
11.2.4 BD Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
11.2.5 BD Recent Development
11.3 bioMérieux
11.3.1 bioMérieux Company Details
11.3.2 bioMérieux Business Overview
11.3.3 bioMérieux Molecular Diagnostics Infectious Disease Testing Introduction
11.3.4 bioMérieux Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
11.3.5 bioMérieux Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Siemens AG
11.6.1 Siemens AG Company Details
11.6.2 Siemens AG Business Overview
11.6.3 Siemens AG Molecular Diagnostics Infectious Disease Testing Introduction
11.6.4 Siemens AG Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
11.6.5 Siemens AG Recent Development
11.7 Veridex
11.7.1 Veridex Company Details
11.7.2 Veridex Business Overview
11.7.3 Veridex Molecular Diagnostics Infectious Disease Testing Introduction
11.7.4 Veridex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
11.7.5 Veridex Recent Development
11.8 Luminex
11.8.1 Luminex Company Details
11.8.2 Luminex Business Overview
11.8.3 Luminex Molecular Diagnostics Infectious Disease Testing Introduction
11.8.4 Luminex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
11.8.5 Luminex Recent Development
11.9 GenMark Diagnostics
11.9.1 GenMark Diagnostics Company Details
11.9.2 GenMark Diagnostics Business Overview
11.9.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Introduction
11.9.4 GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
11.9.5 GenMark Diagnostics Recent Development
11.10 Qiagen NV
11.10.1 Qiagen NV Company Details
11.10.2 Qiagen NV Business Overview
11.10.3 Qiagen NV Molecular Diagnostics Infectious Disease Testing Introduction
11.10.4 Qiagen NV Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
11.10.5 Qiagen NV Recent Development
11.11 Genomix Biotech
11.11.1 Genomix Biotech Company Details
11.11.2 Genomix Biotech Business Overview
11.11.3 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Introduction
11.11.4 Genomix Biotech Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
11.11.5 Genomix Biotech Recent Development
11.12 BioTheranostics
11.12.1 BioTheranostics Company Details
11.12.2 BioTheranostics Business Overview
11.12.3 BioTheranostics Molecular Diagnostics Infectious Disease Testing Introduction
11.12.4 BioTheranostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
11.12.5 BioTheranostics Recent Development
11.13 GenMark Diagnostics
11.13.1 GenMark Diagnostics Company Details
11.13.2 GenMark Diagnostics Business Overview
11.13.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Introduction
11.13.4 GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
11.13.5 GenMark Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Abbott Laboratories
BD
bioMérieux
Thermo Fisher Scientific
F.Hoffmann-La Roche
Siemens AG
Veridex
Luminex
Qiagen NV
Genomix Biotech
Biotheranostics
GenMark Diagnostics
List of Tables
 Table 1. Global Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Bacterial Infectious Disease Testing
 Table 3. Key Players of Viral Infectious Disease Testing
 Table 4. Key Players of Parasitic Infectious Disease Testing
 Table 5. Global Molecular Diagnostics Infectious Disease Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Molecular Diagnostics Infectious Disease Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Molecular Diagnostics Infectious Disease Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Molecular Diagnostics Infectious Disease Testing Market Share by Region (2020-2025)
 Table 9. Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Molecular Diagnostics Infectious Disease Testing Market Share by Region (2026-2031)
 Table 11. Molecular Diagnostics Infectious Disease Testing Market Trends
 Table 12. Molecular Diagnostics Infectious Disease Testing Market Drivers
 Table 13. Molecular Diagnostics Infectious Disease Testing Market Challenges
 Table 14. Molecular Diagnostics Infectious Disease Testing Market Restraints
 Table 15. Global Molecular Diagnostics Infectious Disease Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Molecular Diagnostics Infectious Disease Testing Market Share by Players (2020-2025)
 Table 17. Global Top Molecular Diagnostics Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Infectious Disease Testing as of 2024)
 Table 18. Ranking of Global Top Molecular Diagnostics Infectious Disease Testing Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Molecular Diagnostics Infectious Disease Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Molecular Diagnostics Infectious Disease Testing, Headquarters and Area Served
 Table 21. Global Key Players of Molecular Diagnostics Infectious Disease Testing, Product and Application
 Table 22. Global Key Players of Molecular Diagnostics Infectious Disease Testing, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Molecular Diagnostics Infectious Disease Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Type (2020-2025)
 Table 26. Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Type (2026-2031)
 Table 28. Global Molecular Diagnostics Infectious Disease Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Application (2020-2025)
 Table 30. Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Application (2026-2031)
 Table 32. North America Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Abbott Laboratories Company Details
 Table 48. Abbott Laboratories Business Overview
 Table 49. Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Product
 Table 50. Abbott Laboratories Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 51. Abbott Laboratories Recent Development
 Table 52. BD Company Details
 Table 53. BD Business Overview
 Table 54. BD Molecular Diagnostics Infectious Disease Testing Product
 Table 55. BD Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 56. BD Recent Development
 Table 57. bioMérieux Company Details
 Table 58. bioMérieux Business Overview
 Table 59. bioMérieux Molecular Diagnostics Infectious Disease Testing Product
 Table 60. bioMérieux Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 61. bioMérieux Recent Development
 Table 62. Thermo Fisher Scientific Company Details
 Table 63. Thermo Fisher Scientific Business Overview
 Table 64. Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Product
 Table 65. Thermo Fisher Scientific Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 66. Thermo Fisher Scientific Recent Development
 Table 67. F. Hoffmann-La Roche Company Details
 Table 68. F. Hoffmann-La Roche Business Overview
 Table 69. F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Product
 Table 70. F. Hoffmann-La Roche Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 71. F. Hoffmann-La Roche Recent Development
 Table 72. Siemens AG Company Details
 Table 73. Siemens AG Business Overview
 Table 74. Siemens AG Molecular Diagnostics Infectious Disease Testing Product
 Table 75. Siemens AG Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 76. Siemens AG Recent Development
 Table 77. Veridex Company Details
 Table 78. Veridex Business Overview
 Table 79. Veridex Molecular Diagnostics Infectious Disease Testing Product
 Table 80. Veridex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 81. Veridex Recent Development
 Table 82. Luminex Company Details
 Table 83. Luminex Business Overview
 Table 84. Luminex Molecular Diagnostics Infectious Disease Testing Product
 Table 85. Luminex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 86. Luminex Recent Development
 Table 87. GenMark Diagnostics Company Details
 Table 88. GenMark Diagnostics Business Overview
 Table 89. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product
 Table 90. GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 91. GenMark Diagnostics Recent Development
 Table 92. Qiagen NV Company Details
 Table 93. Qiagen NV Business Overview
 Table 94. Qiagen NV Molecular Diagnostics Infectious Disease Testing Product
 Table 95. Qiagen NV Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 96. Qiagen NV Recent Development
 Table 97. Genomix Biotech Company Details
 Table 98. Genomix Biotech Business Overview
 Table 99. Genomix Biotech Molecular Diagnostics Infectious Disease Testing Product
 Table 100. Genomix Biotech Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 101. Genomix Biotech Recent Development
 Table 102. BioTheranostics Company Details
 Table 103. BioTheranostics Business Overview
 Table 104. BioTheranostics Molecular Diagnostics Infectious Disease Testing Product
 Table 105. BioTheranostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 106. BioTheranostics Recent Development
 Table 107. GenMark Diagnostics Company Details
 Table 108. GenMark Diagnostics Business Overview
 Table 109. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product
 Table 110. GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 111. GenMark Diagnostics Recent Development
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources
 Table 115. Authors List of This Report


List of Figures
 Figure 1. Molecular Diagnostics Infectious Disease Testing Picture
 Figure 2. Global Molecular Diagnostics Infectious Disease Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Molecular Diagnostics Infectious Disease Testing Market Share by Type: 2024 VS 2031
 Figure 4. Bacterial Infectious Disease Testing Features
 Figure 5. Viral Infectious Disease Testing Features
 Figure 6. Parasitic Infectious Disease Testing Features
 Figure 7. Global Molecular Diagnostics Infectious Disease Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Molecular Diagnostics Infectious Disease Testing Market Share by Application: 2024 VS 2031
 Figure 9. Hospital Case Studies
 Figure 10. Laboratory Research Case Studies
 Figure 11. Molecular Diagnostics Infectious Disease Testing Report Years Considered
 Figure 12. Global Molecular Diagnostics Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Molecular Diagnostics Infectious Disease Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Molecular Diagnostics Infectious Disease Testing Market Share by Region: 2024 VS 2031
 Figure 15. Global Molecular Diagnostics Infectious Disease Testing Market Share by Players in 2024
 Figure 16. Global Top Molecular Diagnostics Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Infectious Disease Testing as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Molecular Diagnostics Infectious Disease Testing Revenue in 2024
 Figure 18. North America Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Molecular Diagnostics Infectious Disease Testing Market Share by Country (2020-2031)
 Figure 20. United States Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Molecular Diagnostics Infectious Disease Testing Market Share by Country (2020-2031)
 Figure 24. Germany Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Share by Region (2020-2031)
 Figure 32. China Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Molecular Diagnostics Infectious Disease Testing Market Share by Country (2020-2031)
 Figure 40. Mexico Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Share by Country (2020-2031)
 Figure 44. Turkey Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Abbott Laboratories Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
 Figure 48. BD Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
 Figure 49. bioMérieux Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
 Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
 Figure 51. F. Hoffmann-La Roche Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
 Figure 52. Siemens AG Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
 Figure 53. Veridex Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
 Figure 54. Luminex Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
 Figure 55. GenMark Diagnostics Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
 Figure 56. Qiagen NV Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
 Figure 57. Genomix Biotech Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
 Figure 58. BioTheranostics Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
 Figure 59. GenMark Diagnostics Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Molecular Diagnostics in Infectious Disease Testing Market Research Report 2024
Global Molecular Infectious Disease Testing Market Research Report 2025
Global Viral Molecular Diagnostics Market Research Report 2024
Veterinary Molecular Diagnostics Market
Global Point of care Molecular Diagnostic Solution Market Research Report 2025
Global Molecular Microbiology Market Insights Forecast to 2030
Global Infectious Diseases Molecular Diagnostics Market Research Report 2025
Global Molecular Diagnostics and NAT Market Research Report 2024
Global Sexually Transmitted Diseases Diagnostics Market Research Report 2024
Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2025
Global Nucleic Acids for Molecular Diagnosis Market Research Report 2024
Global Sexually Transmitted Infection Diagnostics Kit Market Research Report 2024
Molecular Diagnostic Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Molecular Diagnostic Reagent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
In Vitro Assays to Diagnose Infectious Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Molecular in Vitro Diagnostics Market Research Report 2024
Global Molecular Diagnostics Cancer Market Insights Forecast to 2030
Global In Vitro Testing for Infectious Diseases Market Research Report 2024
Global Infectious Diseases Diagnostic Market Insights Forecast to 2030
Molecular Diagnostics Devices and Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions